Pinned Tweet
Come learn about latest treatments for #prostatecancer #kidneycancer #bladdercancer. Free for people living with cancer & caregivers. Thanks to friends who provided scholarships.
When: Sept 19
Register/get details:
duke.is/GUCommunityEdu…
@AarmstrongDuke
When: Sept 19
Register/get details:
duke.is/GUCommunityEdu…
@AarmstrongDuke
0
2
14
1,037
We know Black men are at higher risk for #prostatecancer & that a variant T allele increases their risk 3.4 x. The news: if someone has 2 of these T alleles, risk appears 11.4 x. Listen as McManus & Shevach discuss. #ASCO26 @DukeGUCancer @DukeCancer @DukeHealth
3
6
21
2,356
The #ADREAM trial from #ASCO26 offers insight into time off therapy for patients with metastatic prostate cancer and great response to ADT/ARPI. Important data from @ALLIANCE_org. @hannahdzmd @DCockrellMD @DukeGUCancer @AarmstrongDuke @DukeCancer
0
4
18
2,606
Dan George retweeted
Registration is OPEN for #KCRS26! Grab your seat for either in-person or virtual attendance: bit.ly/KCRS26Registra…
Out this week in @OncJournal: a perspective on clinical and translational #kidneycancer research, framed on projects presented at #KCRS. Just in time for this year's conference, which will be in Boston from July 23-24 (in-person and virtual)!
Link to the article in next tweet.
0
1
2
430
World GU just won award for "blending academic rigor with moments of joy and connection . . . using Nashville's Country Music Hall of fame to reframe scientific exchange as storytelling." All that and belt buckles. Wearin' mine at ASCO @CaPsurvivorship @GUconference
Registration is open for the 3rd Annual World GU Conference! Join co-chairs Drs. @CaPsurvivorship & @Daniel_J_George alongside 70+ experts at this FREE 2-day CE-accredited conference on the latest in GU cancers. December 3-5, 2026 in Nashville, TN. Learn more: httprldGU26
1
2
7
677
Dan George retweeted
I'll be presenting the CHAMP multicenter trial results on chemo + immunotherapy for patients with aggressive/neuroendocrine prostate cancer at #ASCO26 abstract 5016 on 5/31! Looking forward to sharing insights with the oncology community! @DukeCancer @ThePCCTC
0
6
29
1,355
Dan George retweeted
Come by the @doximity booth tomorrow at 1:15p where I’ll be presenting on using their #AI tool (Doximity Ask) for assistance in triaging, grading, and managing #immunotherapy toxicity after hours.
Rapid access to patient-specific, @ASCO guideline supported information makes life easier for oncologists and safer for patients.
#ASCO26 #oncology #AIinhealthcare
Rapid access to patient-specific, @ASCO guideline supported information makes life easier for oncologists and safer for patients.
#ASCO26 #oncology #AIinhealthcare
@pshah_88 Featuring:
Dillon Cockrell, MD (@DCockrellMD)
AI for immunotherapy and toxicity management on-call.
Saturday, May 30 | 1:15–1:30 PM CDT
#ASCO26
0
1
1
451
World GU Conf. just won award for "blending academic rigor with moments of joy, emotion, collaboration and connection . . . using Nashville's Country Music Hall of fame to reframe scientific exchange as storytelling." All that and these belt buckles. I'm wearing mine at ASCO.@GUconference
Registration is open for the 3rd Annual World GU Conference! Join co-chairs Drs. @CaPsurvivorship & @Daniel_J_George alongside 70+ experts at this FREE 2-day CE-accredited conference on the latest in GU cancers. December 3-5, 2026 in Nashville, TN. Learn more: httprldGU26
0
1
11
672
Don't miss Susan Hilabi's rapid oral on Sunday 4:30: Liquid biopsy–based biomarkers are moving from correlative tools into clinically actionable risk models. Her study provides a framework for integrating genomics into routine prognostic modeling. @DukeCancer @DukeCancer
0
4
14
1,530
Pts achieving pCR following ICI-based therapy for RCC exhibit more favorable onc outcomes vs pts with residual disease. Long term surveillance still important.
@alirezaghoreifi @DukeCancer #GU26 @MRHarrisonMD
@alirezaghoreifi @DukeCancer #GU26 @MRHarrisonMD
2
6
24
3,588
Dan George retweeted
Time for the Keynote address from @VanAllenLab on Cancer Research & #AI, the hot topic of the last few years in life and in oncology. #GU26
2
3
9
602
Looking forward to this discuss of how we are incorporating new data into clinical practice
@DukeCancer @DukeGUCancer
@DukeCancer @DukeGUCancer
⭐ Coming soon: a new roundtable series on metastatic #RCC featuring panelists @DrChoueiri, @montypal, David McDermott, @ADESAIONCMD, @DrVaishampayan, and @Daniel_J_George!
0
1
11
1,217
Congratulations on this to my colleague Chris Hoimes. @DukeGUCancer @DukeCancer
Big day for #bladdercancer at #GU26 kicks off with much anticipated KNB15/EV304 trial for periop EV plus pembro vs neoadjuvant gem/cisplatin in MIBC. Significant improvements in both EFS and OS (HR 0.65) with pCR 55 vs 32% favoring EV-P. New SOC for #MIBC!
Next questions: How s truly needed? Can we spare surgery for carefully selected patients? ctDNA/utDNA may help answer in the coming years.
@OncoAlert @OncLive @GUOncologyNow @MattGalsky @DrChrisHoimes @BladderCancerUS
0
4
18
1,558
Highlights of #prostatecancer day at #GU26, including AI impacts on practicing-changing research and refreshed guidelines for clinical research @DukeCancer @DukeGUCancer @DCockrellMD
0
4
21
2,339
Family meeting last night with the Duke GUrus. @DukeCancer @DukeGUCancer
@AarmstrongDuke @MRHarrisonMD @DCockrellMD
@AarmstrongDuke @MRHarrisonMD @DCockrellMD
4
5
24
1,656
Congratulations, Masoud! Well done.
Glad to share that I have won the @ConquerCancerFd Merit Award! Happy to see you on poster session this evening at @ASCO #GU26
@NimaSharifiMD @Daniel_J_George @dsui_miami_uro @SylvesterCancer
1
0
6
665
So important to have these updated guidelines as we shape a new generation of clinical trials. Thanks to my colleagues, @AarmstrongDuke #SusanHilabi & so many others for working on them and presenting the results.
Prostate Cancer Working Group 4 at @ASCO #GU26 in press @JCOGO_ASCO
ascopubs.org/doi/pdfdirect/…
Mastefully presented ✌️🗣️👨🏫
@AarmstrongDuke @Daniel_J_George @DukeCancer
@OncoAlert @oncodaily @urotoday @UrologyTimes #cancerresearch #prostatecancer
0
1
7
660
Survey of >500 PC pts showed caregivers R essential partners, monitoring treatment adherence, mental health, side effects & more. Interestingly, female caregivers more engaged. Pts with no caregiver = the most vulnerable. Thnx Dena Battle
@RCCadvocate
@DukeCancer
@RCCadvocate
@DukeCancer
2
6
27
2,589